Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Fem Care Pharma Ltd (524608)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524608 NSE: Household & Personal Products | Small Cap | Fem Care Pharma Share Price
BSE Share Price
Not Listed
Not Listed
Fem Care Pharma Ltd (524608)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524608 NSE: Household & Personal Products | Small Cap | Fem Care Pharma Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹346 Cr.
Current Price
₹0
52-Week Low / High
₹980 / 1,010
TTM EPS
₹52.7
TTM Sales
₹119 Cr.
Book Value per Share
₹166.2
P/E Ratio
18.61
Industry PE
42.6
Price to Book (P/B)
5.90
Price to Sales (P/S)
2.90
EV/EBITDA
13.68
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
32.08%
Return on Capital Employed (ROCE)
25.96%
Return on Assets (ROA)
13.31%
Operating Profit Margin
15.9%
Net Profit Margin
9.98%
Gross Profit Margin
15.4%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
14.67%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
16.35%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
33.67%
Asset Quality
Promoter Holding
92.15%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹55 Cr.
Equity
₹3.5 Cr.
Face Value
₹10
All Time Low / High
₹6.35 / 1040.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'00 | Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 12% | 12% | -13.5% | 15.5% | 40.3% | 49.1% | 50.4% | 60.6% | 17.2% | 27.7% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 23.5 | 28.5 | 32.2 | 34.7 | 39.4 | 44.9 | 51.7 | 68.8 | 93.7 | 107 | 119 |
| Sales YoY Gr. | - | 21.2% | 13.1% | 7.8% | 13.6% | 13.9% | 15% | 33.2% | 36.2% | 14.7% | - |
| Adj EPS ⓘ | -0.4 | 0.9 | -9.7 | 2.7 | 13.7 | 17.2 | 18.8 | 41.6 | 22.4 | 36.2 | 53 |
| YoY Gr. | - | NA | -1189.9% | NA | 407.8% | 25.2% | 9.4% | 121.2% | -46.2% | 62% | - |
| BVPS (₹) ⓘ | 26.6 | 29.9 | 20.9 | 19.6 | 32.5 | 43.8 | 56 | 89.5 | 94.3 | 115.7 | 168.7 |
| Adj Net Profit ⓘ | -0.1 | 0.3 | -2.9 | 0.8 | 4.1 | 5.2 | 5.7 | 12.5 | 6.7 | 12.8 | 19 |
| Cash Flow from Ops. ⓘ | -1.6 | 2.9 | 3.3 | 4.8 | 6.3 | 9.5 | 9.3 | 5 | 7.7 | 14.9 | - |
| Debt/CF from Ops. ⓘ | -8 | 4.3 | 4.5 | 2.1 | 1.3 | 0.3 | 0.3 | 0.6 | 2.3 | 1.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 18.4% | 22.2% | 27.7% | 14.7% | ||||
| Adj EPS ⓘ | NA | 21.5% | 24.5% | 62% | ||||
| BVPSⓘ | 17.8% | 28.9% | 27.3% | 22.7% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'00 | Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -1.3 | 2.8 | -35.6 | 13.1 | 52.4 | 45 | 37.6 | 57.1 | 24.1 | 36.7 | 37.3 |
| Op. Profit Mgn % ⓘ | 8.9 | 9.5 | -8.5 | 14.6 | 17.4 | 18.4 | 17 | 21.6 | 11 | 15.8 | 17.2 |
| Net Profit Mgn % ⓘ | -0.5 | 0.9 | -9.1 | 2.3 | 10.5 | 11.5 | 10.9 | 18.2 | 7.2 | 11.9 | 15.7 |
| Debt to Equity ⓘ | 1.6 | 1.4 | 2.4 | 1.7 | 0.8 | 0.2 | 0.2 | 0.1 | 0.6 | 0.5 | - |
| Working Cap Days ⓘ | 155 | 134 | 124 | 119 | 94 | 76 | 83 | 107 | 117 | 127 | 0 |
| Cash Conv. Cycle ⓘ | 31 | 39 | 46 | 46 | 38 | 17 | -2 | 9 | 13 | 16 | 0 |
Valuation of Fem Care Pharma - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 |
|---|---|---|---|---|---|
| Sales | 60.45 | 70.18 | 81.14 | 93.82 | 107.47 |
| Operating Expenses ⓘ + | 51.60 | 58.66 | 64.94 | 80.06 | 91.46 |
| Operating Profit ⓘ | 8.86 | 11.53 | 16.20 | 13.76 | 16.01 |
| Operating Profit Margin (%) | 14.6% | 16.4% | 20.0% | 14.7% | 14.9% |
| Other Income ⓘ + | 0.78 | 1.16 | 1.40 | 1.02 | 1.80 |
| Interest ⓘ | 0.38 | 0.31 | 0.24 | 0.82 | 1.13 |
| Depreciation ⓘ | 0.65 | 0.70 | 1.78 | 1.89 | 2.59 |
| Profit Before Tax ⓘ | 8.61 | 11.67 | 15.58 | 9.20 | 12.43 |
| Tax ⓘ | 3.24 | 4.66 | 4.17 | 1.19 | 1.71 |
| Profit After Tax | 5.37 | 7.01 | 11.42 | 8.02 | 10.72 |
| PAT Margin (%) | 8.9% | 10.0% | 14.1% | 8.6% | 10.0% |
| Adjusted EPS (₹) | 17.5 | 20.5 | 33.8 | 26.7 | 30.2 |
| Dividend Payout Ratio (%) | 29.10% | 29.30% | 20.70% | 26.30% | 0% |
| PARTICULARS | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 10.47 | 14.04 | 22.47 | 27.82 | 39.04 | ||||||
| Debt + | 2.87 | 3.03 | 3.29 | 17.88 | 19.24 | ||||||
| Minority Interest | 0.5 | 1.36 | 1.64 | 0 | 0 | ||||||
| Trade Payables | 4.93 | 9.32 | 8.31 | 9.09 | 9.27 | ||||||
| Others Liabilities ⓘ | 9.84 | 16.22 | 22.64 | 20.78 | 17.96 | ||||||
| Total Liabilities ⓘ | 28.61 | 43.97 | 58.35 | 75.57 | 85.51 | ||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 10.92 | 10.98 | 20.58 | 34.18 | 33.49 | ||||||
| CWIP ⓘ | 3.18 | 10.09 | 4.92 | 0.52 | 0.14 | ||||||
| Investments ⓘ | 1.51 | 1.22 | 0.06 | 4.56 | 9.30 | ||||||
| Inventories | 3.27 | 5.42 | 13.42 | 9.83 | 10.72 | ||||||
| Trade Receivables | 2.89 | 4.05 | 3.75 | 4.84 | 6.81 | ||||||
| Cash Equivalents | 1.86 | 3.23 | 2.07 | 6.40 | 8.26 | ||||||
| Others Assets ⓘ | 4.98 | 8.99 | 13.55 | 15.23 | 16.79 | ||||||
| Total Assets ⓘ | 28.61 | 43.97 | 58.35 | 75.57 | 85.51 | ||||||
| PARTICULARS | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 9.45 | 9.67 | 5.78 | 12.17 | 18.12 |
| Cash Flow From Investing Activity ⓘ + | -4.86 | -7.07 | -4.81 | -16.49 | -10.45 |
| Cash Flow From Financing Activity ⓘ + | -6.22 | -1.22 | -2.13 | 8.65 | -5.70 |
| Net Cash Flow ⓘ | -1.62 | 1.37 | -1.16 | 4.34 | 1.97 |
| PARTICULARS | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 51.3 | 57.24 | 62.54 | 31.89 | 32.08 | |||||
| ROCE (%) | 67.34 | 78.76 | 73.88 | 27.84 | 25.96 | |||||
| Asset Turnover Ratio | 2.25 | 2.05 | 1.61 | 1.41 | 1.35 | |||||
| PAT to CFO Conversion(x) | 1.76 | 1.38 | 0.51 | 1.52 | 1.69 | |||||
| Working Capital Days | ||||||||||
| Receivable Days | 16.40 | 17 | 17.30 | 16.60 | 19.60 | |||||
| Inventory Days | 18.50 | 21.30 | 41.80 | 44.90 | 34.60 | |||||
| Payable Days | 56 | 81 | 100.90 | 93 | 82.70 | |||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Fem Care Pharma Ltd FAQs
The current trading price of Fem Care Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Fem Care Pharma stood at ₹345.9 Cr
The latest P/E ratio of Fem Care Pharma as of 31-Dec-1969 is 18.50.
The latest P/B ratio of Fem Care Pharma as of 31-Dec-1969 is 5.81.
The 52-week high of Fem Care Pharma is ₹1,010 and the 52-week low is ₹980.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fem Care Pharma is ₹119 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Fem Care Pharma Ltd
Fem Care Pharma Limited (FPL) was originally incorporated as Fem Care Pharma Private Limited on September 3, 1986. Prior to the formation, the business was conducted as a partnership firm since 1982. Subsequently, it was converted to a public company on April 20, 1993 and the name was changed to its current name. The registered office of FPL is situated at Plot no. D-55, MIDC, Additional Industrial Area, Ambad, Nasik - 422010. The Corporate Office of FPL is situated at A/63-65 Mittal Tower, Nariman Point, Mumbai - 400 021 .
Business Profile:
FPL has three divisions’ i.e consumer products, pharmaceutical formulations and specialty chemicals. In the consumer products, FPL manufactures products such as cream bleaches, hair removing cream and liquid hand soaps which are marketed under its flagship brand “FEMâ€. FPL also markets fabric care products under the brand name “Bambi†and herbal anti- wrinkle cream under the brand “Botanicaâ€. In the pharmaceutical category, FPL primarily focuses on dermatology products by manufacturing various Aloe Vera-based creams, hair oils and other prescription-based products.
In the specialty chemicals, FPL manufactures bulk drugs and high value intermediates, which are also exported. FPL has two manufacturing facilities - at Nasik, Maharashtra and one at Baddi, Himachal Pradesh. FPL also exports its products to various countries.
You have 33 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
